Changes

Jump to navigation Jump to search

Patholines:Editorial guidelines

206 bytes added, 10:29, 17 November 2020
:::Generally describe what can be seen rather than processes (such as preferring "an abundance of" rather than "proliferation of").
:*'''Differential diagnoses''', including how to distinguish it from at least the most common and/or important differential diagnoses. There should be no plain list of differential diagnoses (see [[#No plain lists of causes|the section ''No plain lists of causes'']] below). More detailed descriptions of overlapping cases can be described in a template that appears in the main articles of both, such as {{tl|Overlap of squamous-cell and basal-cell carcinoma}}, or as a separate article, such as [[Follicular lymphoma versus reactive follicular hyperplasia]].
::*Any mention of '''immunohistochemistry''' staining should include the conditions that stain helps to indicate. ''Example: [[Lobular carcinoma in situ#Microscopic evaluation|Lobular carcinoma in situ]]''
:*'''Main clinical clues''', such as most common patient age, to help in evaluating the likelihood of the given diagnosis. This should be included ''after'' microscopic characteristics, because it becomes pathologically helpful only if microscopy does not give a definite diagnosis already.
:*'''Further workup''' once the diagnosis is established, which depending on the disease may include:

Navigation menu